Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update

BACKGROUND: Although significant improvement in efficacy measured by a sustained virological response, the high acquisition costs of direct-acting antivirals limit the access for patients and influence the costs of healthcare resource utilisation in hepatitis C. It is important to have the latest es...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ru, Zhou, Junwen, François, Clément, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647266/
https://www.ncbi.nlm.nih.gov/pubmed/31337339
http://dx.doi.org/10.1186/s12879-019-4284-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647266/
https://www.ncbi.nlm.nih.gov/pubmed/31337339
http://dx.doi.org/10.1186/s12879-019-4284-9

Ejemplares similares